You must be signed in to view this page
Vemurafenib: First-in-Class BRAF-Mutated Inhibitor for the Treatment of Unresectable or Metastatic Melanoma
Volume 6, Number 4 (Jul/Aug 2015)
DOI: 10.6004/jadpro.2015.6.4.6
